Company profile for Scopus Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Our strategic partners, City of Hope, NIH and Hebrew University and their respective scientists, medical doctors and other senior researchers with whom we are working at each of our strategic partners are leaders in their respective fields. We collaborate cl...
To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Our strategic partners, City of Hope, NIH and Hebrew University and their respective scientists, medical doctors and other senior researchers with whom we are working at each of our strategic partners are leaders in their respective fields. We collaborate closely with our strategic partners, accelerating the pathway to achieving our mission.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
420 Lexington Avenue New York, New York 10170
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/11/07/2775232/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-Presents-Compelling-New-Data-for-a-Novel-Treatment-for-Malignant-Glioma-at-38th-Annual-Meeting-of-the-Society-for-Immunotherapy-o.html

GLOBENEWSWIRE
07 Nov 2023

https://www.globenewswire.com//news-release/2023/11/02/2772458/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-to-Present-at-the-38th-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer.html

GLOBENEWSWIRE
02 Nov 2023

https://www.globenewswire.com/news-release/2022/11/10/2553395/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-Announces-Key-Scientific-Data-to-be-Presented-at-the-37th-Annual-Meeting-and-Exposition-of-the-Society-for-Immunotherapy-of-Cance.html

GLOBENEWSWIRE
10 Nov 2022

https://www.globenewswire.com/news-release/2022/10/18/2536566/0/en/Scopus-Biopharma-Completes-Recapitalization-Designed-To-Enhance-Shareholder-Value.html

GLOBENEWSWIRE
18 Oct 2022

https://www.globenewswire.com/news-release/2022/05/05/2436835/0/en/Scopus-BioPharma-Announces-Biotechnology-Industry-Leader-Rejoins-Board-of-Directors.html

GLOBENEWSWIRE
05 May 2022

https://www.globenewswire.com/news-release/2022/03/23/2408185/0/en/Scopus-BioPharma-s-Subsidiary-Duet-BioTherapeutics-to-Present-at-the-3rd-Annual-STING-TLR-Targeting-Therapies-Summit.html

GLOBENEWSWIRE
22 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty